Title:
CRYSTALLINE FORM OF A SUBSTITUTED PYRROLIDINE COMPOUND
Document Type and Number:
WIPO Patent Application WO2005123670
Kind Code:
A3
Abstract:
The invention provides a crystalline naphthalene-1,5-disulfonic acid salt of 2-[(S)-1-(8-methylaminooctyl)pyrrolidin-3-yl]-2,2-diphenylacetamide or a solvate thereof. This invention also provides pharmaceutical compositions comprising the salt or prepared using the salt; processes and intermediates for preparing the salt; and methods of using the salt to treat a pulmonary disorder.
More Like This:
Inventors:
LI LI (US)
CHAO ROBERT S (US)
HUGHES ADAM (US)
JI YU-HUA (US)
KHOSSRAVI DAVAR (US)
ZHANG WEIJIANG (US)
CHAO ROBERT S (US)
HUGHES ADAM (US)
JI YU-HUA (US)
KHOSSRAVI DAVAR (US)
ZHANG WEIJIANG (US)
Application Number:
PCT/US2005/020282
Publication Date:
February 09, 2006
Filing Date:
June 09, 2005
Export Citation:
Assignee:
THERAVANCE INC (US)
LI LI (US)
CHAO ROBERT S (US)
HUGHES ADAM (US)
JI YU-HUA (US)
KHOSSRAVI DAVAR (US)
ZHANG WEIJIANG (US)
LI LI (US)
CHAO ROBERT S (US)
HUGHES ADAM (US)
JI YU-HUA (US)
KHOSSRAVI DAVAR (US)
ZHANG WEIJIANG (US)
International Classes:
C07D207/09; A61K31/40; A61P11/06; A61P11/08; C07D207/30
Domestic Patent References:
WO2004041806A2 | 2004-05-21 |
Foreign References:
US20040254219A1 | 2004-12-16 |
Download PDF:
Previous Patent: SUBSTITUTED BICYCLOOCTENES AND THEIR USE AS HERBICIDES
Next Patent: PYRROLE DERIVATIVE
Next Patent: PYRROLE DERIVATIVE